Evidence map›Paper›PMID 38360659›Full record

ArticleStem cell research & therapy2024

The m

Shaoqiong Zhang, Kaile Cui, Yuanyuan Li, Yiting Fan, Dongxu Wang, Xingen Yao, Bo Fang

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shaoqiong Zhang *Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Kaile Cui *Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Yuanyuan LiDepartment of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Yiting FanDepartment of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Dongxu WangDepartment of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Xingen YaoDepartment of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
Bo FangDepartment of Anesthesiology, The First Hospital of China Medical University, Shenyang, China. bfang@cmu.edu.cn.ORCID 0000-0002-4812-6919
First Hospital of China Medical University · CN

Funding

National Natural Science Foundation of China 81971152
6 · The paper itself

Abstract

backgroundIschemia-reperfusion injury to the central nervous system often causes severe complications. The activation of endogenous neural stem cells (NSCs) is considered a promising therapeutic strategy for nerve repair. However, the specific biological processes and molecular mechanisms of NSC activation remain unclear, and the role of N6-methyladenosine (m

methodsNSCs were subjected to hypoxia/reoxygenation (H/R) to simulate ischemia-reperfusion in vivo. m

resultsOverall of m

conclusionThe biological behaviors of NSCs after H/R are closely related to m

Indexed as

HypoxiaNeural Stem CellsAnimalsCell DifferentiationMethylationMiceRNA, MessengerRNA, MessengerDifferentiationHypoxia/reoxygenationMigrationN6-methyladenosine methylationNeural stem cellProliferation

Identifiers

PMID38360659
PMCPMC10870567
OpenAlexW4391880347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.